Asthma is common. Around 10 percent of Americans have the condition, with hundreds of millions more asthmatics worldwide. Though the ubiquity of asthma may be concerning in and of itself, it's a ...

PARIS — Pregnancy is a period of asthma instability; it entails an increased risk for exacerbations. While therapeutic de-escalation, if not the outright cessation of maintenance treatment, is common, ...

Anyone who’s ever suffered from asthma knows all too well that the usual symptoms — wheezing, coughing, and shortness of breath — can upend your day, keep you from being active, and even leave you ...

In the early 20 th century, asthma was thought of as a psychosomatic disease, which means that the illness was caused by psychological problems that lead to development of physical symptoms. At that ...

Asthma biologic use was not associated with an increase in respiratory infection risk, according to results from the 2026 AAAAI Annual Meeting.

Among patients with asthma without diabetes, the risk for exacerbation was decreased with GLP-1 receptor agonist exposure, ...

Add Yahoo as a preferred source to see more of our stories on Google. what-is-asthma-jpg The wheezing. The coughing. The extreme and sudden shortness of breath. These are symptoms that are attached to ...

This summer’s family barbecue was supposed to be a celebration of sorts—coming together for the first time since the pandemic pulled the plug on group activities. But your joy was cut short by an ...

PITTSBURGH (KDKA) - University of Pittsburgh researchers have developed a new nasal swab test to determine Asthma subtype results for kids. The study which was conducted by Dr. Juan Celedón a ...

Dr. Wasserman answers the question: 'Standard Treatment Strategy For Asthma?' — -- Question: What is the standard treatment strategy for asthma? Answer: The standard treatment of asthma is to ...

Please provide your email address to receive an email when new articles are posted on . Corticosteroid use during pregnancy was not linked with developmental milestone delays. Beta-2 adrenergic ...

The European Commission on Tuesday approved GSK plc’s GSK Exdensur (depemokimab) in two indications, including: As an add-on ...